Literature DB >> 16891618

Activation of primary T lymphocytes results in lysosome development and polarized granule exocytosis in CD4+ and CD8+ subsets, whereas expression of lytic molecules confers cytotoxicity to CD8+ T cells.

David T Shen1, Jennifer S Y Ma, Jacques Mather, Stanislav Vukmanovic, Sasa Radoja.   

Abstract

Lytic granule exocytosis is the major cytotoxic mechanism used by CD8(+) cytotoxic lymphocytes. CD8(+) T cells acquire this effector function in the process characterized by lysosomal biogenesis, induction of expression of cytolytic molecules, and their selective sorting into the lysosomal vesicles. However, temporal relation of these differentiation stages during T cell activation has not been defined precisely. Also, although CD4(+) T cells typically do not express lytic molecules as a consequence of activation, and therefore, do not acquire granule exocytosis-mediated lytic function, it is not clear whether CD4(+) T cells are able to degranulate. By using in vitro TCR stimulation of primary mouse lymphocytes, we found that polyclonally activated CD4(+) T cells degranulate upon TCR ligation and polarize enlarged lysosomal granules in response to target cell recognition, despite the lack of granule exocytosis-mediated cytotoxicity. Upon TCR stimulation, resting CD8(+) T cells rapidly express lytic molecules and acquire potent lytic function early in activation. Maximal cytolytic potential, however, depends on enlargement of lysosomal granules during the subsequent activation stages. Thus, polyclonal TCR stimulation of resting T cells results in development of lysosomal granules and their release upon TCR engagement in CD4(+) and CD8(+) T cells, but only CD8(+) T cells acquire lytic function as a result of induction of expression of lytic molecules.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16891618     DOI: 10.1189/jlb.0603298

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  8 in total

1.  Characterisation of the T cell and dendritic cell repertoire in a murine model of mucopolysaccharidosis I (MPS I).

Authors:  Louise D Archer; Kia J Langford-Smith; William R Critchley; Brian W Bigger; James E Fildes
Journal:  J Inherit Metab Dis       Date:  2012-07-07       Impact factor: 4.982

2.  Zinc transporter ZIP8 (SLC39A8) and zinc influence IFN-gamma expression in activated human T cells.

Authors:  Tolunay B Aydemir; Juan P Liuzzi; Steve McClellan; Robert J Cousins
Journal:  J Leukoc Biol       Date:  2009-04-28       Impact factor: 4.962

3.  Protein kinase Cdelta regulates antigen receptor-induced lytic granule polarization in mouse CD8+ CTL.

Authors:  Jennifer S Y Ma; Ngozi Monu; David T Shen; Ingrid Mecklenbräuker; Nadezda Radoja; Tarik F Haydar; Michael Leitges; Alan B Frey; Stanislav Vukmanovic; Sasa Radoja
Journal:  J Immunol       Date:  2007-06-15       Impact factor: 5.422

4.  The effects of BAFF on T lymphocytes in chronic obstructive pulmonary disease.

Authors:  Shupei Gao; Jinqing Chen; Jungang Xie; Jianmiao Wang
Journal:  Respir Res       Date:  2020-03-11

5.  Circulating mature granzyme B+ T cells distinguish Crohn's disease-associated axial spondyloarthritis from axial spondyloarthritis and Crohn's disease.

Authors:  Adam R Lefferts; Emilie H Regner; Andrew Stahly; Becky O'Rourke; Mark E Gerich; Blair P Fennimore; Frank I Scott; Alison E Freeman; Ken Jones; Kristine A Kuhn
Journal:  Arthritis Res Ther       Date:  2021-05-22       Impact factor: 5.156

Review 6.  Intra- and Extracellular Effector Vesicles From Human T And NK Cells: Same-Same, but Different?

Authors:  Marcus Lettau; Ottmar Janssen
Journal:  Front Immunol       Date:  2021-12-23       Impact factor: 7.561

7.  Divergent effects of norepinephrine, dopamine and substance P on the activation, differentiation and effector functions of human cytotoxic T lymphocytes.

Authors:  Carina Strell; Anne Sievers; Philipp Bastian; Kerstin Lang; Bernd Niggemann; Kurt S Zänker; Frank Entschladen
Journal:  BMC Immunol       Date:  2009-12-08       Impact factor: 3.615

8.  Impact of Pegylated Interferon-alfa-2a on Perforin Level in Patients With Chronic Hepatitis B; Preliminary Study.

Authors:  Meisam Mahdavi; Houshang Amirrasouli; Seyed Moayed Alavian; Bita Behnava; Faranak Kazerouni; Maryam Keshvari; Saeed Namaki; Mohammad Gholami Fesharaki; Hooman Rahimipour; Jahangir Mohammadzade; Farahnaz Zohrehbandian; Fazel Mahdavipour
Journal:  Hepat Mon       Date:  2013-11-23       Impact factor: 0.660

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.